# Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery

> **NCT00237328** · — · COMPLETED · sponsor: **Duke University** · enrollment: 1015 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT00237328
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-03
- **Final completion:** 2012-07
- **Target enrollment:** 1015 (ACTUAL)
- **Last updated:** 2013-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00237328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00237328, "Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00237328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*